- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05386316
The Maternal Health Multilevel Intervention for Racial Equity (MIRACLE) Project (MIRACLE)
Meeting Women Where They Are: The Maternal Health Multilevel Intervention for Racial Equity (MIRACLE) Project
Study Overview
Status
Detailed Description
Maternal morbidity and mortality in the US are critical problems of public health significance. US maternal mortality rates are the highest among high-income countries. In addition, severe maternal morbidity (SMM; "unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman's health"1), affects around 60,000 US women every year. Such life-threatening complications affect mothers, children, families, and communities, and cost billions of dollars per year.
These challenges disproportionately affect African American (AA) women. AA women are three to four times more likely to die of pregnancy related complications than non-Hispanic white (NHW) women and have twice the rates of SMM.2,3 Inequities occur at many levels. These include the community level, in which the built environment and working multiple jobs while managing family obligations can make it difficult for AA women to access even enhanced prenatal and postnatal care (EPC) programs designed for them. At the provider/practice level, implicit and explicit biases and the structures and practices reflecting them contribute to inadequate quality of care for AA women, reduce the acceptability of treatment, and contribute to racial disparities in maternal morbidity and mortality. At the system level, health systems serving AA women are less likely to offer high-quality care, and quality initiatives that to do not directly target disparities often have little or no effect on disparities.
This proposal will test the effectiveness and cost-effectiveness of a multilevel intervention to address AA-NHW maternal morbidity and mortality disparities in two Michigan counties: Genesee County (which includes Flint) and Kent County (which includes Grand Rapids). Interventions at each level were developed or co-developed by our partners in these counties, who include AA women residents and community leaders, EPC staff (including Community Health Workers), and physician/health system representatives.
Community level (improving accessibility) intervention. This project will expand access to EPC services using telehealth and flexible scheduling (e.g. outside business hours). EPC programs (such as Healthy Start and statewide home visiting programs) provide care coordination, promote healthy behaviors, provide health education and social support, and address social determinants of health. These programs, some using race-matched Community Health Workers, improve maternal and infant health, including reducing mortality, especially for AA. Despite being designed for minority women, 60% of eligible AA women in Michigan do not enroll in EPC services. The investigators found that 50% of minority women who declined EPC services said they would participate if a tele-health option was available. This project will provide this option to improve access to these important services.
Provider/practice level (improving acceptability) intervention. This project will address provider and health system implicit and explicit bias and corresponding structures and practices and make this learning actionable using daylong experiential trainings. Trainings will include didactics, reflection, discussion, windshield tours, and brainstorming ways to tailor trainees' settings to better hear, respect, and meet the needs of perinatal AA women. Training will include everyone from physicians to front desk staff and will take place in small groups (10-20) with additional opportunities for the larger community to come together to brainstorm and plan responses.
System level (improving quality) intervention. This project will deploy community care patient safety bundles targeting maternal health disparities throughout the intervention counties. Community care is defined as care provided by outpatient, EPC, and community-based organizations. Kent County is the lead of 5 pilot communities in the national Alliance for Innovation on Maternal Health Community Care Initiative (AIM-CCI) to develop and implement non-hospital focused maternal safety bundles. The bundles provide care guidelines to address disparities in preventable maternal mortality and SMM. As part of this project, Genesee County will implement the bundles in partnership with Kent County, providing the final level of our multilevel intervention.
The study sample will include all Medicaid insured women observed during pregnancy, at birth, and/or up to 1 year postpartum, who deliver in Michigan from 2016-2019 and 2021-2024 (~540,000 births, including ~162,000 births to AA women). Investigators will test the effects of the multilevel intervention using a quasi-experimental difference-in-difference with propensity scores approach to compare pre (2016-2019) to post (2022-2025) changes in outcomes among Medicaid women in the two intervention counties with similar women in other counties. Measures will be taken from a pre-existing linked dataset that includes Medicaid claims, death records, birth records, and EPC program data. The specific aims are to:
Assess the effectiveness of the multilevel intervention on the following outcomes:
- AA SMM and pregnancy-related mortality (up to 1-year postpartum; overall & relative to NHW women)
- AA non-severe maternal morbidity (overall & relative to NHW women)
- Test improved service utilization (enrollment in EPC, more outpatient visits, fewer emergency department [ED] visits during pregnancy and postpartum) and non-severe maternal morbidity (overall & relative to NHW women) as mechanisms of the effect of the multilevel intervention on SMM
- Evaluate the cost-effectiveness of the multilevel intervention
AA women face addressable disparities in maternal morbidity and mortality. This trial, among the first to evaluate a multilevel intervention to address population-level AA SMM, will help build the evidence-base to address them. The study will also provide information about cost-effectiveness needed to drive policy decisions and information about mechanisms of intervention effects needed to drive the science forward. Achieving these aims will deter-mine whether this intervention could be scaled widely to reduce AA SMM and pregnancy-related mortality.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Flint, Michigan, United States, 48502
- Michigan State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: Resided in intervention county at time of delivery. -
Exclusion Criteria: None.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention counties
Birthing persons who live in Kent County or Genesee County, Michigan, USA at the time of delivery.
|
In addition to standard enhance prenatal care (EPC) services, the following will be offered. Community level. We will make EPC services (i.e., MIHP and Healthy Start) available via telehealth with flexible hours to women who are eligible for Healthy Start (primarily minority women) who decline traditional (i.e., home visiting) services. Provider/practice level. We will provide actionable maternal health-focused anti-racism training to health system administrators, physicians, residents, midwives, nurses, front desk staff, schedulers, public health officers, EPC staff, doulas, WIC staff, and lactation consultants. System level. Counties will implement equity focused community care maternal safety bundles. Community care is care provided by outpatient, EPC, community-based organizations, and linkages between hospital care and these settings. Pregnant women in comparison counties will receive whatever EPC services (MIHP and/or Healthy Start) they naturalistically choose to receive. Maternal Infant Health Program (MIHP). All women in Michigan who are Medicaid insured are eligible for MIHP. MIHP offers monthly home visiting and care coordination to supplements regular care during pregnancy and up to 12 months post birth. MIHP offers care coordination; risk assessment; individual care plan; evidence-based interventions; transportation; education; and referrals. Healthy Start. Health Start is a federally funded program for minority women that offers more intensive EPC services delivered by race/ethnicity matched community health workers. Community health workers offer peer support; resilience and problem solving; risk assessment; facilitating provider-client communication; collaborative care; system navigation, including transition from prenatal care to postnatal primary care; and supportive referrals. |
ACTIVE_COMPARATOR: Control counties
Birthing persons who live in the other Michigan, USA counties at the time of delivery.
|
Pregnant women in comparison counties will receive whatever EPC services (MIHP and/or Healthy Start) they naturalistically choose to receive. Maternal Infant Health Program (MIHP). All women in Michigan who are Medicaid insured are eligible for MIHP. MIHP offers monthly home visiting and care coordination to supplements regular care during pregnancy and up to 12 months post birth. MIHP offers care coordination; risk assessment; individual care plan; evidence-based interventions; transportation; education; and referrals. Healthy Start. Health Start is a federally funded program for minority women that offers more intensive EPC services delivered by race/ethnicity matched community health workers. Community health workers offer peer support; resilience and problem solving; risk assessment; facilitating provider-client communication; collaborative care; system navigation, including transition from prenatal care to postnatal primary care; and supportive referrals. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
severe maternal morbidity
Time Frame: Pregnancy through 12 months postpartum
|
We will assess severe maternal morbidity (SMM, as defined by CDC and ACOG)4 using CDC's list of 21 SMM indicators based on ICD-10 diagnosis and procedure codes.60
The binary overall SMM indicator will be coded 1 if any SMM will be identified during a woman's pregnancy, delivery, and up to 12 months postpartum using Medicaid claims and 0 otherwise.
|
Pregnancy through 12 months postpartum
|
severe maternal morbidity + pregnancy-related mortality
Time Frame: Pregnancy through 12 months postpartum
|
An indicator representing yes/no any SMM and/or pregnancy-related mortality
|
Pregnancy through 12 months postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
non-severe maternal morbidity
Time Frame: pregnancy through 12 months postpartum
|
Measurement of "non-severe" maternal morbidity (NSMM), is taken from the WHO's Maternal Morbidity Working Group (MMWG).61-64
Most NSMM are measurable using ICD-10 diagnostic and procedure codes63,65 To capture multimorbidity in our sample, the overall NSMM indicator will be the sum of WHO-delineated NSMM diagnoses and procedures63,65 identified in a woman's Medicaid claims during pregnancy and up to 1 year postpartum.
We will also assess the following WHO-defined subcategories: (1) number of direct NSMM diagnoses and procedures (e.g., delivery complications, hypertensive disorders of pregnancy, obstetric hemorrhage, pregnancy-related infections);63 (2) number of indirect NSMM diagnoses and procedures (e.g.
endocrine, nutritional, and metabolic diseases; mental disorders); and (3) number co-incidental NSMM (e.g.
partner violence, sexual assault) diagnoses and procedures.63
|
pregnancy through 12 months postpartum
|
enrollment in enhanced prenatal care
Time Frame: pregnancy through 12 months postpartum
|
Binary indicator reflecting yes/no enrollment in MIHP and/or Health Start
|
pregnancy through 12 months postpartum
|
outpatient visits
Time Frame: pregnancy through 12 months postpartum
|
Number of outpatient pregnancy and postpartum visits (higher is better)
|
pregnancy through 12 months postpartum
|
emergency department visits
Time Frame: pregnancy through 12 months postpartum
|
Number of emergency department visits (lower is better)
|
pregnancy through 12 months postpartum
|
cost-effectiveness
Time Frame: pregnancy through 12 months postpartum
|
The primary outcome used for cost-effectiveness analyses will be SMM.
Prevented SMM will be monetized using Medicaid claims data by calculating the difference between Medicaid delivery expenditures between women with SMM and without SMM using our own claims data and prior estimates.6
Secondary cost-effectiveness measures will be maternal mortality and NSMM.
The value of a statistical life,66 currently around $10 million, will be used to monetize prevented maternal deaths.
For NSMM, we will calculate intervention costs per point of NSMM score reduction.
|
pregnancy through 12 months postpartum
|
Collaborators and Investigators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- R01MD016003 (NIH)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Disparities
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...RecruitingHealth Care DisparitiesUnited States
-
VA Office of Research and DevelopmentCompletedMental Health | Healthcare DisparitiesUnited States
-
Fundacio Salut i Envelliment UABRecercaixa; Equip Atencio Primaria SardenyaCompletedAging | Self Care | Health Literacy | Social Capital | Subjective Health | Health Status Disparities
-
Plan A Health, IncOrganonEnrolling by invitationHealthcare Disparities | Reproductive Health | Sexual Health | Health Care Quality, Access, and Evaluation | Program EvaluationUnited States
-
National Cancer Institute (NCI)CompletedNeoplasm | Healthcare Disparities | Health Services Accessibility | Outcome AssessmentUnited States
-
Oregon Health and Science UniversityEnrolling by invitationHealthcare Disparities | Minority Health | RacismUnited States
-
Harvard Medical School (HMS and HSDM)National Institute on Minority Health and Health Disparities (NIMHD); Abdul...Not yet recruitingHealth Disparities | Food Security
-
Boston Children's HospitalAgency for Healthcare Research and Quality (AHRQ); Pediatric Research in Inpatient...RecruitingQuality Improvement | Patient Safety | Family Reported Errors and Adverse Events | Health Disparities | Family Safety Reporting | Voluntary Incident ReportingUnited States
-
University of Illinois at ChicagoNational Institute of Dental and Craniofacial Research (NIDCR)CompletedDental Caries in Children | Health Behavior | Healthcare DisparitiesUnited States
-
Cedars-Sinai Medical CenterCalifornia Breast Cancer Research ProgramRecruitingFaith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean WomenHealth Knowledge, Attitudes, Practice | Breast Cancer Female | Health Disparities | Cancer ScreeningUnited States